Blood Testing in Prague

Fasting blood glucose measurement for diabetes screening.

A full blood count (CBC) with white cell differential at MEDILA's ČSN EN ISO 15189-accredited laboratory. The CBC is the foundational haematology test measuring red blood cell count, haemoglobin, haematocrit, MCV/MCH/MCHC indices, platelet count, and total white cell count. The 5-part differential classifies white cells into neutrophils, lymphocytes, monocytes, eosinophils, and basophils, providing a comprehensive picture of immune cell distribution. Together these measurements identify anaemia by type (iron deficiency, B12/folate, haemolytic), infection burden, inflammatory activation, and haematological conditions. No fasting is required. Walk-in collection is available Monday to Friday at MEDILA collection centres, with results typically available the same or next working day.

Complete blood count with white blood cell differential analysis.

Includes glucose, creatinine, urea, and uric acid for kidney function assessment.

Focused liver function assessment measuring the three key hepatic enzymes: ALT, AST, and GGT. At 101 CZK (~4 EUR), one of the cheapest liver screens available anywhere in Central Europe — ideal for routine monitoring or screening patients on hepatotoxic medications.

INR test for patients on anticoagulant medications to monitor clotting time.

A core metabolic biochemistry panel at MEDILA covering glucose, HbA1c, creatinine, urea, and ALT — the foundational metabolic markers used to screen for and monitor diabetes, kidney function, and early liver disease in a single fasting blood draw. Glucose provides the acute blood sugar level; HbA1c reflects the 3-month average, the definitive diabetes screening and monitoring marker. Creatinine and urea assess kidney filtration capacity and excretory function. ALT is the primary liver health marker, elevated early in fatty liver, hepatitis, and hepatotoxic medication use. These five markers together form the minimal baseline biochemistry screen recommended in Czech preventive medicine guidelines for adults over 40. No appointment required at MEDILA collection centres. Fasting of 8–12 hours required for glucose and HbA1c.

Complete lipid profile measuring total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides. Essential for cardiovascular risk assessment using the European SCORE2 calculator. At 169 CZK (~7 EUR), roughly one-fifth the cost of the same four-marker panel at a German private lab.

Thyroid hormone testing at MEDILA starting with TSH (thyroid-stimulating hormone) — the single most sensitive marker for thyroid dysfunction and the international standard first-line thyroid screen. TSH rises in hypothyroidism and falls in hyperthyroidism, providing early detection before overt symptoms develop. Free T4 (the main circulating thyroid hormone) and Free T3 (the active form) can be added to complete the functional assessment. Autoimmune thyroid markers — Anti-TPO and Anti-TG for Hashimoto's thyroiditis, TRAK for Graves' disease — are individually orderable for patients with suspected autoimmune thyroid disease. No fasting is required for any thyroid marker. MEDILA holds ČSN EN ISO 15189 accreditation from the Czech Accreditation Institute. Results returned within one week.

Kidney function assessment measuring creatinine, urea, and electrolytes. Calculates estimated glomerular filtration rate (eGFR) for chronic kidney disease staging. At 218 CZK (~9 EUR), a focused renal assessment at a fraction of Western European pricing.

Diabetes screening combining fasting glucose and glycated haemoglobin (HbA1c) — the two complementary markers for detecting and monitoring glucose metabolism disorders. At 220 CZK (~9 EUR), a focused and affordable screen for the most common metabolic disease worldwide.

Entry-level health screening package covering blood count, fasting glucose, liver enzymes, cholesterol, triglycerides, creatinine, and urinalysis. At 229 CZK (~9 EUR), this is one of the cheapest basic blood screens available in Central Europe — roughly one-fifth the cost of a comparable panel in Germany.

A fasting cholesterol and lipid panel at MEDILA measuring the four core cardiovascular risk markers: total cholesterol, HDL-cholesterol (protective), LDL-cholesterol (primary atherogenic marker), and triglycerides. This panel is the standard lipid screen used to assess cardiovascular risk in adults and to guide decisions about lifestyle changes and lipid-lowering therapy. LDL elevation is the primary target for cardiovascular risk reduction — European guidelines recommend LDL below 1.8 mmol/L for very high risk patients and below 2.6 mmol/L for high risk. HDL below 1.0 mmol/L in men and 1.2 mmol/L in women indicates reduced protective function. Triglycerides above 1.7 mmol/L signal metabolic syndrome risk. MEDILA's ISO 15189-accredited laboratories process fasting lipid panels with results returned within one week.

A 12-lead electrocardiography (EKG/ECG) examination at Infuze Pomáhá for cardiac rhythm screening and cardiovascular prevention. The EKG records the electrical activity of the heart through electrodes placed on the chest, wrists, and ankles, producing a 12-view map of cardiac conduction. Results are immediate. At 250 CZK it is the same price as the clinic's biophysical therapy sessions and serves as an accessible preventive cardiac check — particularly for clients who have never had an EKG, those with family history of cardiovascular disease, anyone experiencing palpitations, fatigue, or unexplained shortness of breath, and as a pre-treatment safety screen before commencing a course of IV infusions. Non-invasive with no contraindications.

A 3-parameter diabetes risk assessment panel available at 290 Kč through cz.unilabs.online, testing insulin, fasting glucose, and glycated haemoglobin (HbA1c) to determine diabetes or pre-diabetes status without a GP referral. HbA1c provides a 3-month average blood glucose picture, fasting glucose captures the current level, and insulin reveals insulin resistance before glucose even rises — making this the most sensitive early-warning combination available at this price point. Results within 3 business days. Rated 4.95/5. Recommended for those with symptoms (extreme thirst, frequent urination, fatigue), family history, or overweight.

Quick antigen testing with immediate results.

Rapid antibody screening test.

Prostate-specific antigen for prostate cancer screening.

Carcinoembryonic antigen for colorectal and other cancer monitoring.

Standard blood count analysis including RBC, WBC, platelets, hemoglobin.

Thyroid function assessment measuring TSH, free T3, and free T4. Screens for both hypothyroidism and hyperthyroidism by evaluating pituitary signalling and circulating active hormone levels. At 379 CZK (~15 EUR), approximately one-third the cost of an equivalent three-marker thyroid panel in Germany.

A 10-parameter kidney and urinary tract function panel available at 390 Kč through cz.unilabs.online, collected at any of 136 Czech collection points. Kidney disease is described by Unilabs as 'the most treacherous disease' because it produces no symptoms until function is significantly compromised. This panel screens for the key blood markers of glomerular filtration rate and tubular function — creatinine, urea, uric acid, key electrolytes, and phosphate — in a single venous blood draw. An optional morning urine sample extends the assessment. Rated 4.92/5 from 285 reviews.

A 9-parameter liver function blood panel available at 390 Kč through cz.unilabs.online, covering the standard hepatic enzyme and metabolite profile in a single venous blood draw at any of 136 Czech collection points. The liver processes every substance absorbed from the gut and is the primary site of detoxification, protein synthesis, bile production, and glycogen storage. The panel screens for cell damage (ALT, AST, GGT), cholestatic disease (ALP, bilirubin), and synthetic function (albumin). Results within 4 business days. Rated 4.93/5.

A 10-parameter kidney and urinary tract function panel available at 390 Kč through cz.unilabs.online, collected at any Unilabs Prague location. Kidney disease is described by Unilabs as 'the most treacherous disease' because it produces no symptoms until function is significantly compromised — by the time pain, swelling, or visible urine changes appear, damage is often substantial. This panel screens for the key blood markers of glomerular filtration rate and tubular function — creatinine, urea, uric acid, key electrolytes, and phosphate — in a single venous blood draw. An optional morning urine sample extends the assessment. Rated 4.92/5 from 285 reviews.